Nouscom announces first patient dosed in a Phase 1b Trial with NOUS-PEV, a novel personalized cancer immunotherapy, in advanced melanoma or lung cancer : vimarsana.com

Nouscom announces first patient dosed in a Phase 1b Trial with NOUS-PEV, a novel personalized cancer immunotherapy, in advanced melanoma or lung cancer

Nouscom announces first patient dosed in a Phase 1b Trial with NOUS-PEV, a novel personalized cancer immunotherapy, in advanced melanoma or lung cancer

prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Rome , Lazio , Italy , United Kingdom , Belgium , Ankara , Turkey , Switzerland , Spain , Edinburgh , City Of , Eleanor Perkin , Prnewswire Nouscom , Rick Davis , Stefan Symeonides , Sylvie Berrebi , Patricia Delaite , Marina Udier , Linkedin , University Of Edinburgh , Department Of Oncology , Medical Oncologist , Clinical Scientist , Modified Vaccinia Ankara , Chief Medical Officer , Chief Executive Officer , Mark Swallow Phd , Encoded Neoag Unrestricted Selection ,